Contra: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”
- 1 January 2009
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 102 (11) , 914-915
- https://doi.org/10.1160/th09-08-0563
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial FibrillationAnnals of Internal Medicine, 2010
- Atrial fibrillation and stroke risk prevention in real-life clinical practiceThrombosis and Haemostasis, 2009
- Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatmentThrombosis and Haemostasis, 2009
- Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patientsThrombosis and Haemostasis, 2009
- Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'Thrombosis and Haemostasis, 2008
- Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxisThrombosis and Haemostasis, 2008